GMAB
Genmab A/S
NASDAQ · Healthcare · Biotechnology · DK
$33.60
−2.35%Forward multiples
Based on analyst estimates
- P/E forward
- 25.87x
- P/E 2026E
- 28.86x
- P/E 2027E
- 19.47x
- P/E 2028E
- 12.99x
- P/S forward
- 4.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.31x
- PEG TTM
- 15.43x
- Price / book
- 3.47x
- Price / sales
- 5.00x
- Price / cash flow
- 23.19x
Enterprise value
- Enterprise value
- $24.4B
- EV / sales
- 5.91x
- EV / EBITDA
- 20.03x
- EV / EBIT
- 18.31x
- Market cap
- $20.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026